chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient arrived at the local HD for a booster dose of Pfizer COVID-19 vaccine. The patient received her primary series out of state.  RN verified that no doses were given in state database. Dates of original vaccine series was not written on patient's consent form. RN called patient after she left the HD to get primary series dose dates to enter them historically in database. Patient stated that the 2nd dose date was 09/02/2021. RN realized booster dose was inadvertently given 13 days before 5 month mark. Informed patient of inadvertent dose. Contacted CDC line for guidance.
Pfizer-BioNTech COVID-19 Vaccine EUA: During observation, vaccine recipient had a near syncope event. They were diaphoretic. They were monitored by the EMS. No further intervention.
Patient was given expired flu vaccine. Expiration was 7/2022.  Error was noted the following day. No reaction present. Currently working closely with our medical director to determine the best next course of action.
Several hours after 1st injection, I began to experience severe (scale of 9) bone pain in both of my legs top to bottom.  Followed with general body ache.  Ability to completely fall asleep was gone.  It was like I was one of those dimmer switches and instead of being able to turn off the light I only get to the dimmer settings.  I?m needing to take ambient to fall asleep.  And now I continue to suffer bone pains on both my knees, shoulders and fingers.  Have lost quite a bit of weight unplanned.  Lacking appetite.
Covered with eczema from head to toe and suddenly had a yeast rash forming in all her folds and creases and behind her ears which did not respond well to treatment with antifungals. After about a week the yeast rash began to crack and bleed. Within hours of vaccination, she began to cry inconsollably for several hours. Once the eczema and yeast formed, she became very fussy and barely slept for two months.
3cm localized reaction with redness and swelling. No cellulitis, minimal tenderness.
Within 24 hour developed headache, body ache, chills, then hot but no recorded fever.
This spontaneous report as received from a nurse refers to a multiple unspecified patients of unknown demographics. Information regarding the patient's concurrent conditions, medical history and drug reactions/allergies was not provided. On unspecified dates in 2016, the patients were vaccinated with improperly stored doses of VAQTA which had lot# L034381 and expiration date 21-DEC-2016; lot# K004856 and expiration date 07-DEC-2016; lot# L026600 and expiration date 15-MAR-2016 (dose, route of administration and anatomical location were not reported). There were no concomitant medications provided. The reporter stated that there was no previously temperature excursion. On 25 and 26-FEB-2016, the VAQTA were exposed to 9 Celsius (C) for 10 hours each day and a data logger was used to capture the excursion. No adverse effects reported. This is one of several cases from the same reporter. Additional information has been requested.
Case received from a patient, who is a healthcare professional, on 16 Nov 2005. A female patient (age unknown) had received an injection of influenza vaccine (Fluzone, lot unknown), as yearly, in left deltoid on 14 Oct 2005. On 18 Oct 2005, i.e. 4 days later, she developed a bilateral rash on legs (thigh area) of purpuric appearance, which spread to arms, forehead, face and neck. She felt swollen when warm with burning sensation. There was no itching. The symptoms resolved approximately within 3 weeks. Follow up information  received on 03/Feb/2006 from a health care provider. No treatment was received, and there was no infectious disease investigation or etiological work-up.  The lot number is provided as U1753AA. The patient had not experienced symptoms following previous vaccinations.
she is still sick and is not recovered; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: Solution for injection, Lot number and Expiration date: unknown), via an unknown route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, the patient taken the first dose of the Pfizer COVID-19 vaccine. She has heard people had adverse reactions right after getting the vaccine, but her adverse events occurred right now, which was 15 days after her first dose. Her second shot appointment was due in 4 days and she was still sick and was not recovered. She said that she has all the COVID-19 symptoms, and she has taken a test today and still waiting for the results. She wanted to know if she can take the vaccine even if she was sick. As noted in the Fact Sheet for Recipients, she should not get the Pfizer-BioNTech COVID-19 Vaccine if she had a severe allergic reaction after a previous dose of the vaccine or if she had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason cannot be made by Pfizer. The patient should speak to her healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. The outcome of the event was not resolved.  Information about lot/batch number cannot be obtained. Additional information has been requested.
Mini stroke followed a few weeks later by inability to walk. Rapid onset. Hospitalized  for 2 weeks.  Extensive testing showed trace pericardial effusion and acute lacunae infarction involving the right thalamus.  Micro vascular ischemic changes.  Critical test result of acute stroke.
Very high anxiety; abdominal pain; foggy thought process; Daily headaches; This is a spontaneous report from a contactable consumer (Patient). An 39 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19May2021 18:00 (Lot number: EW0182) at the age of 39 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing); "ADHD" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). Concomitant medication(s) included: ABILIFY; WELLBUTRIN; TRAZODONE; HYDROXYZINE; VYVANSE. Vaccination history included: Bnt162b2 (Covid vaccine details: Product COVID 19, Brand: Pfizer, Lot number: EWO172, Administration time: 06:00 PM, Vaccine location: Left arm, Dose number 1), administration date: 28Apr2021, when the patient was 39 years old, for COVID-19 immunization, reaction(s): "No reaction reported". The following information was reported: ANXIETY (non-serious) with onset 20May2021, outcome "not recovered", described as "Very high anxiety"; ABDOMINAL PAIN (non-serious) with onset 20May2021, outcome "not recovered", described as "abdominal pain"; THINKING ABNORMAL (non-serious) with onset 20May2021, outcome "not recovered", described as "foggy thought process"; HEADACHE (non-serious) with onset 20May2021, outcome "not recovered", described as "Daily headaches". Therapeutic measures were not taken as a result of anxiety, abdominal pain, thinking abnormal, headache.  Additional information: Facility type vaccine: Hospital. If other vaccine in four weeks: No. Adverse event: Very high anxiety, abdominal pain, foggy thought process. Daily headaches. Had been extremely well controlled until 2nd vaccine. If covid prior vaccination: No. If covid tested post vaccination: No. Device time stamp: 01Jun2021.Facility where the most recent COVID-19 vaccine was administered: Hospital. Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. No new medically significant information.  Follow-up attempts are completed. No further information is expected.
Zostavax 8/21/07. Hive-like lesions started 9/7 - pt thought initial lesion (8/25) on her stomach was Lymes disease and started herself on Doxycycline 8/25-9/6. Seen 9/9 - doc says hives, pt says was told was a vaccine. When I saw it 9/9 - each lesion had a tiny vesicle and was very itchy.
About an hour after the injection, my arm was sore at the injection site and became redden, hot to the touch and swollen with tiny, white looking whelps in the center. This reaction has only increased in size and now is the approximately the size of a half dollar. I?ve applied cold compresses and taken Tylenol for the mild pain but neither  remedy is helping.
Pharmacy did not realize patient's age prior to giving first dose of vaccine.  Mom still wants patient to get 2nd vaccine, but age permitting pharmacy is not sure how to proceed.
(L) thigh rash. Mild and faint erythematous macular area w/faint borders located on anterior thigh from proximal to midline. No pain or edema. Onset x 3 days. Monitor sxs (conservative mngmt).
Pt was given flu vax & began c/o pain @ site down to the entire lt arm; 3 min later, entire lt arm went numb; Pt began crying & hyperventilating;
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Mar-2021 at 1:13 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) outcome was unknown. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient age was reported as 64.46. No concomitant medication was provided. It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F. No treatment medication was provided.
This spontaneous report was received from a registered nurse and refers to a 4 year old male patient. The patient did not have any pertinent medical history, concomitant therapies or any known drug reactions or allergies. On 12-OCT-2016, the patient was vaccinated with an improperly stored dose of PROQUAD injection, subcutaneously (lot # M018636 with an expiration date 11-OCT-2016), albumin status rHA (dose and anatomical location were not reported). On 12-OCT-2016, reported as immediately after receiving PROQUAD, the patient experienced pain at the injection site and a "small bump" at the injection site. The nurse reported that the patient stayed in the waiting room for "a few minutes" and the pain subsided but was not resolved when the patient left the office. No treatment was given for the events and no diagnostic lab studied were performed. The outcome of the event of "small bump" at the injection site was not reported. The relatedness between the events and PROQUAD was not reported. This is one of two reports received from the same reporter. Additional information has been requested.
Approximately two weeks after administration, patient developed shingles like rash on both arms and legs and required treatment by medical facility.
12 HOURS LATER, I STARTED TO HAVE A HEADACHE, CHILLS, FEVER, BURNING EYES, COUGH. I WAS SWEATING TOO.  IT LASTED UNTIL SUNDAY 12TH AT NIGHT. MY BODY IS EXHAUSTED.
1049 in immunizations room and just received TDaP, MCV4, and HPV. Head went down and unresponsive for 5 seconds. Came to with verbal and tactile stimulation. Pale and c/o light headedness.  1050 assisted to lying down on exam table. BP 101/59 HR 43 Pale and c/o light headedness.  AO X3 Mom at bedside and updated on status.  1052 Dr. at bedside. Pt. AO X3. 1055 Slowly to sitting position BP 9057 HR 52. Denies light headedness at this time. Remains slightly pale. 1100 Assisted to waiting area and instructed to remain in waiting area for 20 minutes and if no further sx will administer Hep A vaccine per  her request. Instructed on drinking water and cup of water given to her. Parents both with her. Remains slightly pale, but color improving. Instructed for future HPV's to tell provider what happened and have vaccine adminsitered while lying down. Verbalizes understanding. 1120 Denies light headedness. Color improved. Hepatitis A administered. 1130 no further sx. Instructed to not do any strenuous exercise or work today and to drink increased water. Her and  her mother verbalize understanding.
Minor dry cough began Saturday, got slowly worse Sunday, turned into sore throat with dry cough Monday, became bad flu like symptoms yesterday and this morning. I took robitussin starting Sunday night, Monday night, and last night and this morning. Also took aspirin Saturday and Sunday. The cough has become productive this morning, spitting up wads of flem.
NUMBNESS FROM THE WAIST DOWN, LOSS OF FEELING SENSATION (GENITAL AREA), LOSS OF LIBIDO, SUDDEN LOSS OF MEMORY, SWOLLEN LEGS..ARE SOME OF THE ADVERSE EVENTS THE PATIENT IS BEING EXPERIENCING. AT THIS MOMENT PATIENT IS SEEKING TREATMENT AT THE HOSPITAL REGARDING IS LEG & WAIST(NUMBNESS) CONDITION, HIS INABILITY TO NORMALLY FUNCTION (SEXUALLY), AS WELL AS PSYCHOLOGICAL THERAPY. MOST OF THIS EVENTS ARE BEING TAKEN PLACE ONCE THE PATIENT RETURNED FROM DEPLOYMENT ON FEB 2005, AFTER SPENDING ONE YEAR ON THEATER.  02/21/2007 MR received.  Called contact in MR to request EMG full report. Multiple visits beginning 07/03/2006 through 12/10/2007. Initial visit 07/03/2006 for c/o chronic low back pain and shoulder pain.  Also reports anxiety, decreased libido and intermittant numbness over hand, leg, and shoulders. PE: normal, except left forearm scar. Impression: Chronic back and shoulder pain w/o focal neuro deficits or evidence of acute musculoskeletal disorder. Also seen by Psychiatry same day with above complaints and in addition: forgetfulness and increased irritability.  Mental Status Exam WNL except for sad mood and constricted affect. F/u 08/16/2006 for EMG/NCVS for numbness, tingling, and burning sensation in both legs accompanied by back pain.  To R/O radiculopathy vs. neuropathy. PE of 11/06/2006 notes that patient voids well, no changes in urine stream. Otherwise WNL except for a skin fungal infection.
Received flu shot, pt was experiencing gradual muscle pain where immunization occurred. At night, its hard for pt to lift arm w/o excruciating pain. Pt came in on Monday (12/14/15) to complain Rph wrote up VAERS.
Initial report received on 15 January 2007 from a health care professional. A 41-year-old female patient, who denied any concurrent illnesses, and who is allergic to Septra, and has a history hypothyroidism, increase cholesterol and migraines, had received a left deltoid, intramuscular injection of ADACEL, lot number C2644AA, on 12 January 2007. At the time of the vaccination, the patient was taking concomitantly Levoxyl, Lipitor, Seasonale, Zyrtec, Midrin (prn), and multivitamins. Approximately eight hours post-immunization, the patient complained of rigors, headache, skin sensitivity, and mouth ulcers. The rigors lasted approximately 24-36 hours. The patient did not seek medical attention. Treatments received and diagnostic testing performed were not reported. At the time of this report, the patient was still complaining of headache and weakness, and it was unknown if the skin sensitivity and mouth ulcers were still persisting. The patient has not fully recovered. Follow-up information received on 31 January 2007. The patient did not have any illness at the time of vaccination. The patient did speak with a physician who advised Benadryl and Motrin. No testing done. The patient fully recovered in 3-4 days. The final diagnosis for the adverse events was unknown.
This spontaneous report was received from a female patient of unknown age, who was reporting on herself. The patient's concurrent conditions, concomitant medications, pertinent medical history and drug reactions or allergies were not provided. On an unknown date, the patient was vaccinated with an unspecified pneumonia vaccine (manufacturer unknown) (strength, dose, route of administration, lot # and expiration date were not reported) and FLUZONE (strength, dose, route of administration, lot # and expiration date were not reported), High-Dose vaccines, in the same arm about an inch apart. On an unknown date, the patient experienced a temperature. On an unknown date, the site where she thought the unspecified pneumonia vaccine was given, was raised, hot, beet red. On an unknown date, all she wanted to do is sleep. The patient did not seek medical attention and no treatment was given for the events. The outcome of the events was reported as not recovered/not resolved. The relatedness between the events and the suspect therapies was not assessed by the reporter.
HCP stated they had a patient who received his 1st dose of Moderna and 1 year later he received a Bivalent booster instead of the 2nd dose of the primary series; No adverse event; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Apr-2023 and was forwarded to Moderna on 07-Apr-2023.    This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (HCP stated they had a patient who received his 1st dose of Moderna and 1 year later he received a Bivalent booster instead of the 2nd dose of the primary series) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (HCP stated they had a patient who received his 1st dose of Moderna and 1 year later he received a Bivalent booster instead of the 2nd dose of the primary series) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (HCP stated they had a patient who received his 1st dose of Moderna and 1 year later he received a Bivalent booster instead of the 2nd dose of the primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (HCP stated they had a patient who received his 1st dose of Moderna and 1 year later he received a Bivalent booster instead of the 2nd dose of the primary series).    Patient had received 1st dose of Moderna vaccine one year before the Bivalent booster instead of the 2nd dose of the primary series.  No concomitant medications were reported. No treatment details were reported.   Reporter did not allow further contact
2 weeks from when I got my vaccine, while I was sleeping at night I got a stabbing pain in my calf. Then the next day it spread to my entire body. Then 2 days later it was tingle everywhere lasting a few seconds and stabbing pain everywhere lasting  a few seconds. It's been going on now for a week and hasn't stopped.
Discomfort in abdomen and lower back, which started shortly after the second vaccination shot in May. Got a physical to rule out other causes. Discomfort has pretty much gone away now, which makes me think it was related to that second vaccine shot. Thought it was important to report.
Pain at injection site (Normal).  After that I experienced redness traveling down my arm and swelling traveling down my arm to my elbow.  Extreme fatigue the day after the injection. It has been 2 days to the hour since my flu shot.  The swelling and redness have increased and are approximately 8" from the injection site, traveling down the arm.
severe body aches, joint aches, for two days, followed by vomiting , severe head pain, head spins, nervousness stomach, diarrhea and despair for a few weeks.   I cancelled the second shot, I don't feel strong enough to do the second shot, was not expecting severe reactions with the first shot.
pt recvd vax;about 5 hrs later had shivering & staring spell of about 1/2-1 min per mom;no clear postictal state;mom recorded T of 99.6 axillary;
I had a runny nose, fever, severe aches and pains. I took a home COVID-19 test, that came back positive. I called my doctor to let her know I had tested positive, we discussed my symptoms, she prescribed Paxlovid, I started taking it that day. It took a week for me to start feeling better. I felt better for three days then the symptoms started to come back. I tested positive again on January 23 and it took me two weeks to finally get better. I tested negative on February 07, 2023. On February 24, 2023, I tested positive for polymyalgia rheumatica that my doctor feels may have been triggered by my having COVID-19.
After the vaccination I developed a rash on my upper right leg that was elevated. I also experienced a rash on my upper left leg as well. The rash became very irritated.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with the improperly stored dose ZOSTAVAX (lot # M019646, expiration date 18-JUL-2017, subcutaneously; dose was not reported). No adverse effects were reported. The vaccine was stored in 10F for 48 hours and on the another date, in 10F for 24 hours. The call was made because of the data logger. This is one of several reports received from the same source. Additional information has been requested.
Rash and welts on arm that appeared 8 days later at injection site- 4 were raised about 1/2 inch, hot and itchy.
Sore muscles, achey bones, fever, headache, nausea. Lasted until the end of day when I fell asleep. Medicine did not help.
chest pain, hard to breathe, dizziness. Ran tests came back looking normal. Thought it looked like acid reflex or food intolerances. A few days later, symptoms are getting worse, now with eating difficulties.
Significant swelling and purple discoloration of distal left lower extremity with moderate swelling of distal right lower extremity and b/l distal upper extremities.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Pt given flu shot and Moderna booster in L arm. She moved chairs so I could provide same thing to her dad: as I was providing his flu shot she said she felt lightheaded; When i finished his shot dad noticed she looked wobbly and her eyes were rolling around. I held her shoulders and asked if her dad could help me lay her down and keep her legs elevated. She lost consciousness briefly but opened her eyes pretty quickly when her mom asked her if she was ok (she replied YES);ems came & assessedher